Earnings4565Nxera Pharma Co.,Ltd.
Nxera Pharma Reports Q2 Revenue of 18.9 billion, Up 25%
TOKYO, Aug 07 (Pulse News Wire) – Nxera Pharma Co., Ltd. (4565.T) reported consolidated results for Q2 FY2026 (ending December 2026).
Revenue was ¥18.9 billion (+25.3% YoY). operating profit was ¥6,494 million.
Net profit was ¥1,399 million. The full-year forecast for the current fiscal year is revenue of ¥18.9 billion (+15.0%).
Financial results — FY2026/12 (consolidated)
| Metric | Current | YoY |
|---|---|---|
| Revenue | ¥18,910M | +25.3% |
| Operating profit | ¥6,494M | n/a |
| Net profit | ¥1,399M | n/a |
Figures in millions of yen
End of article